Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 28 of 35
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
NCT01144780
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
NCT01020812
Testing an Internet-Based Intervention for Preventing Eating Disorders
NCT00934583
Regional Fat Depots and Insulin Resistance
NCT01336777
Anemia in the Elderly
NCT00640172
Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
NCT01406821
Efficacy Study to Evaluate Laparoscopic Fascial Closure Device
NCT01024296
Insulin Resistance in Patients With Major Depression
NCT01106313
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009
NCT02133781
Behaviorally Enhanced Counseling on Nicotine Dependence (BEACON) Trial.
NCT00991081
Adding Sleep Intervention to Traditional Diet and Exercise Approach to Weight Loss
NCT01135342
Incidence of Simultaneous Epidural and Intravascular Injection
NCT01020929
Trial of Aripiprazole in Trichotillomania
NCT00947154
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
NCT00962494
MRI Laryngeal Imaging With a Surface Coil
NCT00965003
Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
NCT00946673
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
NCT01078363
Cutaneous Administration of Local Anesthetic for Spine Injection Procedures
NCT00756301
Advanced Gastrointestinal Endoscopic Imaging
NCT01034670
Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
NCT00985140
A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
NCT01364285
Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis
NCT00879190
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
NCT00899847
Study of T3 for the Treatment of Fibromyalgia
NCT00903877
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.
NCT00878826
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
NCT00896493
A Prospective Trial of Ultrasound Versus Landmark Guided Central Venous Access in the Pediatric Population
NCT01680666
LASIK Using the Alcon Allegretto Wavefront-Guided Excimer Laser vs AMO Visx Wavefront-Guided Excimer Laser
NCT01454843
Wavefront-guided PRK vs Wavefront-optimized PRK
NCT02091934
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
NCT00926536
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients
NCT01419275
Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)
NCT00890929
Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Anemia
NCT01011361
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
NCT00928226
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
NCT00890552
Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
NCT00957931
Lymphedema Study for Arm or Leg Lymphedema
NCT02257970
Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids
NCT01222091
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
NCT00780494
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
NCT00850135
Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease
NCT01421719
Functional MRI Before and After Treatment for Depression
NCT00896441
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
NCT01144754
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
NCT01071434
Intellectual Impairment in Women With Breast Cancer
NCT00896324
Study of Treatment for Adolescents With Bulimia Nervosa
NCT00879151
Outcome Measures in Infant/Early Childhood Lung Disease w/ Chest CT Scanning & Lung Function Testing
NCT01158495
A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer
NCT00477139
Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial
NCT00822926
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.